Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2022/esmo-2022-prostate-cancer/139440-esmo-2022-differential-treatment-response-with-nodal-metastases-in-mhspc-and-evaluation-of-nodal-burden-as-a-prognostic-biomarker-ancillary-studies-of-the-docetaxel-and-abiraterone-acetate-
If you do not want to visit that page, you can close this browser tab.
